News

Feb 21, 2012

Ceptaris Secures $15M in Venture Debt Financing
Read more here

Feb 20, 2012

Firm Logs Instant Feedback on Doctor Visits
Read more here

Feb 07, 2012

CarePartners Plus® Launches Wellby® — A New Innovative Patient Engagement and Feedback Technology Tool
Read more here

Feb 01, 2012

Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
Read more here

Jan 18, 2012

Ceptaris Therapeutics Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel
Read more here

Jan 17, 2012

Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
Read more here

Jan 13, 2012

Niiki Pharma Developing New Weapons to Battle Cancer
Read more here

Jan 05, 2012

Yaupon Changes Name to Ceptaris Therapeutics, Inc.
Read more here

Jan 03, 2012

Ossianix Announces Lundbeck Investment
Read more here